Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction

• Anna Witasp,

  Affiliation Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Mikael Rydén,

  Affiliation Department of Medicine (H7), Karolinska Institutet, Stockholm, Sweden

  ⨯
• Juan Jesús Carrero,

  Affiliations Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden, Center for Gender Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Abdul Rashid Qureshi,

  Affiliation Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Louise Nordfors,

  Affiliations Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Erik Näslund,

  Affiliation Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Folke Hammarqvist,

  Affiliation Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Samsul Arefin,

  Affiliation Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Karolina Kublickiene,

  Affiliations Center for Gender Medicine, Karolinska Institutet, Stockholm, Sweden, Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Peter Stenvinkel

  * E-mail: peter.stenvinkel@ki.se

  Affiliation Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯